Stay updated on Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now lists multiple study sites across CT, FL, IL, ME, MA, NC, OH, PA, SC, and TN under the Locations section.
    Difference
    0.9%
    Check dated 2025-12-24T14:48:38.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added the principal investigator, Lauren Carcas, MD, and contact email; expanded recruitment sites to Kendall and Plantation, FL (Miami Cancer Institute at Baptist Health), bringing total locations to 14, and updated the Last Update Posted (Estimated) to 2025-12-03.
    Difference
    1%
    Check dated 2025-12-10T02:08:36.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Publications are now described as automatically filled from PubMed and the page records Revision: v3.3.2, replacing the previous wording tied to PubMed-derived entries and Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page no longer displays the general government funding status notice, a site-wide banner not specific to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:32:18.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    No significant changes detected; minor wording and formatting adjustments across the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T21:06:53.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    - Added a prominent operations/uptime notice and current status guidance, including a link to cc.nih.gov and opm.gov. - Updated the version to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:25:31.000Z thumbnail image

Stay in the know with updates to Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.